Concepedia

Pottayil G. Sasikumar

PG

Statistics

Publications

13

Citations

452

H-Index

11

Active since

2002

Affiliations

Aurigene Discovery Technologies (India)(Current)

National Cancer Institute

University of Washington

Sarah Cannon Research Institute

Olivia Newton-John Cancer Wellness & Research Centre

Pottayil G. Sasikumar is an author at Aurigene Discovery Technologies (India) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2002–2021

13

Publications

13

PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, Srinivas Adurthi et al. · Communications Biology · 2021 · 144 citations · Full text

Anti-PD-L1 peptide improves survival in sepsis

Yuichiro Shindo, Jacquelyn S. McDonough, Katherine Chang et al. · Journal of Surgical Research · 2016 · 109 citations · Full text

, , +6

A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy

Pottayil G. Sasikumar, Raghuveer Ramachandra, Srinivas Adurthi et al. · Molecular Cancer Therapeutics · 2019 · 61 citations · Full text

A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events

Pottayil G. Sasikumar, Rajeev Shrimali, Sreenivas Adurthi et al. · Journal for ImmunoTherapy of Cancer · 2013 · 19 citations · Full text

, , +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

1–5 of 13